Transplant Center Attitudes Toward Early Liver Transplant for Alcohol-associated Liver Disease

被引:3
|
作者
Mitchell, Jonathan [1 ]
Herrick-Reynolds, Kayleigh [2 ]
Motter, Jennifer D. [1 ]
Teles, Mayan [1 ]
Kates, Olivia [3 ]
Sung, Hannah [1 ]
Chen, Po-Hung [3 ]
King, Elizabeth [1 ]
Cameron, Andrew [1 ,4 ]
机构
[1] Johns Hopkins Univ, Dept Surg, Sch Med, Baltimore, MD USA
[2] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA
[4] Johns Hopkins Sch Med, Dept Surg, 720 Rutland Ave, Ross 765, Baltimore, MD 21205 USA
来源
TRANSPLANTATION DIRECT | 2023年 / 9卷 / 09期
基金
美国国家卫生研究院;
关键词
FOLLOW-UP; PREDICTORS; ABSTINENCE; RELAPSE;
D O I
10.1097/TXD.0000000000001532
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Many centers have removed 6-mo pretransplant alcohol abstinence requirements to provide early liver transplant (ELT) for individuals with severe alcohol-associated liver disease (ALD), but the practice remains controversial. Using data collected from a nationally distributed survey, this study examines the practices and attitudes of transplant centers in the United States regarding ELT. Methods. A 20-item survey designed to assess center practices and provider attitudes was distributed to 225 medical and surgical directors from 143 liver transplant centers via email. Results. Surveys were completed by 28.9% (n = 65) of directors and 39% (n = 56) of transplant centers. All responding centers reported evaluating patients for ELT. Circumstances for considering ELT included <6 mo of survival without a transplant (96.4%) and inability to participate in alcohol addiction therapy pretransplant (75%). Most (66%) directors indicated their center had established criteria for listing candidates with severe ALD for ELT. Regarding important factors for ELT candidate listing, 57.1% indicated patient survival, 37.5% indicated graft survival, and 55.4% indicated having a low risk of relapse. Only 12.7% of directors affirmed the statement, "Six months of pretransplant abstinence decreases the risk of relapse."Conclusions. More centers are providing ELT for severe ALD. Inability to participate in alcohol addiction therapy and <6 mo of survival are commonly reported circumstances for considering ELT. Continued investigation of posttransplant outcomes in patients receiving ELT is essential to establishing a national consensus for distributing this valuable resource.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] POST-TRANSPLANT OUTCOMES IN ALCOHOL-ASSOCIATED LIVER DISEASE AND UNTREATED ALCOHOL USE DISORDER
    Azhari, Hassan
    Havlichek, Daniel, III
    Watt, Kymberly
    Taner, Timucin
    Sanchez, William
    Schneekloth, Terry D.
    Simonetto, Douglas A.
    HEPATOLOGY, 2021, 74 : 862A - 863A
  • [22] SEX DIFFERENCES IN LIVER TRANSPLANT OUTCOMES IN PATIENTS WITH ALCOHOL ASSOCIATED LIVER DISEASE ( ALD) REFERRED FOR EARLY LIVER TRANSPLANT EVALUATION
    Cooper, Katherine M.
    Devuni, Deepika
    HEPATOLOGY, 2023, 78 : S1648 - S1649
  • [23] EVALUATING THE IMPACT OF PRE-LIVER TRANSPLANT ACUTE-ON-CHRONIC LIVER FAILURE ON POST-LIVER TRANSPLANT PROGNOSIS IN PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE
    Lee, David
    Lee, Ki Jung
    Yerneni, Sharmitha
    Bhowmick, Kuntal
    Cha, Youngjae
    Yi, Andrew
    Lee, KeeSeok
    Fan, Gregory
    Urrunaga, Nathalie
    HEPATOLOGY, 2024, 80 : S510 - S511
  • [24] Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis
    Lee, Brian P.
    Roth, Nitzan
    Rao, Prathik
    Im, Gene Y.
    Vogel, Alexander S.
    Hasbun, Johann
    Roth, Yoel
    Shenoy, Akhil
    Arvelakis, Antonios
    Ford, Laura
    Dawe, Inga
    Schiano, Thomas D.
    Davis, Jordan P.
    Rice, John P.
    Eswaran, Sheila
    Weinberg, Ethan
    Han, Hyosun
    Hsu, Christine
    Fix, Oren K.
    Maddur, Haripriya
    Ghobrial, R. Mark
    Therapondos, George
    Dilkina, Bistra
    Terrault, Norah A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (07) : 1834 - 1841
  • [25] Alcohol-Associated Liver Disease
    Jophlin, Loretta L.
    Singal, Ashwani K.
    Shah, Vijay H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (03): : 495 - 499
  • [26] Alcohol-associated liver disease
    Mackowiak, Bryan
    Fu, Yaojie
    Maccioni, Luca
    Gao, Bin
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (03):
  • [27] National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States
    Lee, Brian P.
    Vittinghoff, Eric
    Dodge, Jennifer L.
    Cullaro, Giuseppe
    Terrault, Norah A.
    JAMA INTERNAL MEDICINE, 2019, 179 (03) : 340 - 348
  • [28] Recidivism for Non-Alcoholic Fatty Liver Disease and Alcohol-Associated Liver Disease in Liver Transplant: Is All Recidivism Treated Equally?
    Robinson, Benjamin L.
    Ciobanu, Camelia
    Russell, Gregory B.
    Russo, Mark W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1124 - S1124
  • [29] ALCOHOL USE DISORDER TREATMENT IN PATIENTS WITH ALCOHOL USE AFTER LIVER TRANSPLANT SEEN IN A MULTIDISCIPLINARY ALCOHOL-ASSOCIATED LIVER DISEASE CLINIC
    Reagan, Jeffrey Schwartz Meghan
    Anand, Akhil
    Sengupta, Shreya
    HEPATOLOGY, 2024, 80 : S1015 - S1015
  • [30] Liver transplantation for Alcohol-associated liver disease
    Simonetto, Douglas A.
    Winder, G. Scott
    Connor, Ashton A.
    Terrault, Norah A.
    HEPATOLOGY, 2024, 80 (06) : 1441 - 1461